Claim Terms Must Be Construed in Light of the Entire Issued Patent
Justin E. Gray on
Wednesday, July 28, 2010 at 4:32 PM
Sun Pharmaceutical Industries, Ltd. v. Eli Lilly and Company (Fed. Cir. Jul. 28, 2010)
In this case, the Federal Circuit held that the "the relevant specification for claim construction purposes is that of the issued patent, not an early version of the specification that may have been substantially altered throughout prosecution."
The district court found Eli Lilly's '826 patent invalid for obviousness-type double patenting over its '614 patent. Both patents related to the drug gemcitabine. The '614 patent claimed gemcitabine as well as a method of using gemcitabine for treating viral infections. The '826 patent claimed a method of using gemcitabine for treating cancer.
The specification of the original application that resulted in the '614 patent described only gemcitabine's utility for antiviral purposes. During prosecution, a continuation-in-part was filed that resulted in the '614 patent and added a description of gemcitabine's anticancer utility to the specification, though the '614 patent did not claim a method of using gemcitabine for treating cancer. This continuation-in-part was filed the same day as the application that ultimately issued as the '826 patent.
While a "claim to a method of using a composition is not patentably distinct from an earlier claim to the identical composition in a patent disclosing the identical use", Pfizer, Inc. v. Teva Pharmaceuticals USA, Inc., 518 F.3d 1353, 1363 (Fed. Cir. 2008), Eli Lilly argued that the district court used the wrong specification in construing the '614 patent claim relating to the gemcitabine compound. Eli Lilly asserted that the court should have used the earlier-filed application (i.e. the one that only described gemcitabine's utility for antiviral purposes, not for cancer purposes) instead of the specification of the ultimately issued patent, as Phillips stated that claim terms should be given their ordinary and customary meaning "the term would have to a person of ordinary skill in the art in question at the time of invention, i.e., as of the effective date of the patent application."
The Federal Circuit disagreed, stating that "our claim construction precedent establishes that claim terms must be construed in light of the entire issued patent … the relevant specification for claim construction purposes is that of the issued patent, not an early version of the specification that may have been substantially altered throughout prosecution." The court therefore affirmed the finding of obviousness-type double patenting.










